CRS: BJMC
Position: Lab Manager
Position: TB Laboratory Coordinator
CRS:
Position:
ACTG A5324 is a phase IV randomized, double-blinded, placebo-controlled study to assess the efficacy of adding Maraviroc (MVC)...
This study will compare the efficacy and safety of 26 weeks of delamanid (DLM) versus 26 weeks of isoniazid (INH) for preventing...
A5361s is a prospective study to determine the effects of pitavastatin on physical function. The study will enroll participants...
IMPAACT P1026s, the predecessor of this study, was first approved in 2003. P1026s enrolled over 1000 pregnant/postpartum women,...
The investigators are looking for a better way to prevent cervical cancer. This study is comparing two different methods to...
